Discovery of TQ-3959 as a Potent and Orally Bioavailable BTK PROTAC Degrader Incorporating a Novel Benzisoxazole-Based CRBN Ligand for the Treatment of B-Cell Malignancies
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-08-07 17:00:58 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1021/acs.jmedchem.5c00956
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c00956
其他信息:
出版社: American Chemical Society (ACS)
作者: Jing Ren; Yongkang Huang; Jinan Wang; Sheng Xu; Lei Wang; Qingrui Yan; Xiaoping Zhang; Lilong Wang; Qinglin Wang; Xiaojin Wang; Ying Zhang; Hengqiao Shen; Lijuan Zhu; Shuwen Xue; Mincheng Zhang; Hongjiang Xu; Baomin Liu
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c00956